EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-SA 4.0

Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature

Haleigh Dawn Stafford, Grace L. Lee

Asian Journal of Pediatric Dermatology · 2024

DOI: 10.4103/ajpd.ajpd_25_24 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Asian Journal of Pediatric Dermatology, 2024. Verfasst von Haleigh Dawn Stafford und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Netherton syndrome (NS) is an inherited ichthyosis without targeted therapies, and current treatment remains largely symptomatic. Herein, we report the case of a 6-year-old patient with NS successfully managed with dupilumab for 3 years. The literature regarding dupilumab treatment in this patient population is summarized, and the potential role of dupilumab in altering the pathogenesis of NS is discussed.

Zitieren

APA

Stafford, H. D., & Lee, G. L. (2024). Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature. Asian Journal of Pediatric Dermatology. https://doi.org/10.4103/ajpd.ajpd_25_24

Vancouver

Stafford HD, Lee GL. Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature. Asian Journal of Pediatric Dermatology. 2024. doi:10.4103/ajpd.ajpd_25_24

BibTeX
@article{Stafford2024,
  author = {Stafford, Haleigh Dawn and Lee, Grace L.},
  title = {Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature},
  journal = {Asian Journal of Pediatric Dermatology},
  year = {2024},
  doi = {10.4103/ajpd.ajpd_25_24}
}
Kostenlos starten →